Quale sarebbe il prezzo per Valeo Pharma Inc. (VPHIF)

Il prezzo per Valeo Pharma Inc. (VPHIF) è $0.0001

Qual è la capitalizzazione di mercato per Valeo Pharma Inc. (VPHIF)

La capitalizzazione di mercato per Valeo Pharma Inc. (VPHIF) è $9.87K

Ricavi di Valeo Pharma Inc. (VPHIF)

Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.

Anno	Ricavi	Cambia
Non abbastanza dati per le date fornite.

Anno

Ricavi

Cambia

Non abbastanza dati per le date fornite.

Azienda	Ricavi	Differenza nei ricavi	Il paese
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Azienda

Ricavi

Differenza nei ricavi

Il paese